Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.

[1]  K. Matuschewski,et al.  Post‐transcriptional silencing of UIS4 in Plasmodium berghei sporozoites is important for host switch , 2014, Molecular microbiology.

[2]  K. Williamson,et al.  A rapid sensitive, flow cytometry-based method for the detection of Plasmodium vivax-infected blood cells , 2014, Malaria Journal.

[3]  Roger Le Grand,et al.  Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures , 2014, Nature Medicine.

[4]  J. Baird.  Malaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life — averting the infectious bite preempts these hazards , 2013 .

[5]  Anne E Carpenter,et al.  A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. , 2013, Cell host & microbe.

[6]  A. Vaughan,et al.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain‐2 during asexual blood‐stage development , 2013, Cellular microbiology.

[7]  A. Thomas,et al.  Transgenic Fluorescent Plasmodium cynomolgi Liver Stages Enable Live Imaging and Purification of Malaria Hypnozoite-Forms , 2013, PloS one.

[8]  A. Vaughan,et al.  Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. , 2012, The Journal of clinical investigation.

[9]  S. Kappe,et al.  Plasmodium yoelii Macrophage Migration Inhibitory Factor Is Necessary for Efficient Liver-Stage Development , 2012, Infection and Immunity.

[10]  C. Rodrigo,et al.  Primaquine in vivax malaria: an update and review on management issues , 2011, Malaria Journal.

[11]  N. White.  Determinants of relapse periodicity in Plasmodium vivax malaria , 2011, Malaria Journal.

[12]  J. Carlton,et al.  Why Is Plasmodium vivax a Neglected Tropical Disease? , 2011, PLoS neglected tropical diseases.

[13]  Caroline W. Kabaria,et al.  The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009 , 2010, PLoS neglected tropical diseases.

[14]  A. Aly,et al.  Plasmodium falciparum PF10_0164 (ETRAMP10.3) Is an Essential Parasitophorous Vacuole and Exported Protein in Blood Stages , 2010, Eukaryotic Cell.

[15]  R. Price,et al.  New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance , 2009, Current opinion in infectious diseases.

[16]  A. Vaughan,et al.  Type II fatty acid synthesis is essential only for malaria parasite late liver stage development , 2008, Cellular microbiology.

[17]  I. Verma,et al.  Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model , 2007, Proceedings of the National Academy of Sciences.

[18]  Aarati R. Ranade,et al.  Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice , 2007, Nature Biotechnology.

[19]  J. Sattabongkot,et al.  Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. , 2006, The American journal of tropical medicine and hygiene.

[20]  S. Kappe,et al.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Kappe,et al.  Differential transcriptome profiling identifies Plasmodium genes encoding pre‐erythrocytic stage‐specific proteins , 2004, Molecular microbiology.

[22]  J. Adams,et al.  Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont. , 2000, Molecular and biochemical parasitology.

[23]  S. Hoffman,et al.  Identification and Characterization of the Protective Hepatocyte Erythrocyte Protein 17 kDa Gene of Plasmodium yoelii, homolog of Plasmodium falciparum Exported Protein 1* , 1996, The Journal of Biological Chemistry.

[24]  J. Sattabongkot,et al.  Phenotype and genotype diversity in the circumsporozoite proteins of Plasmodium vivax in Thailand. , 1995, Molecular and biochemical parasitology.

[25]  S. Lindstedt,et al.  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I , 1995, Nature Genetics.

[26]  K. Haldar,et al.  Identification and localization of ERD2 in the malaria parasite Plasmodium falciparum: separation from sites of sphingomyelin synthesis and implications for organization of the Golgi. , 1993, The EMBO journal.

[27]  J. Sattabongkot,et al.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. , 1989, Science.

[28]  C. C. Campbell,et al.  Electron microscopy of Plasmodium vivax exoerythrocytic schizonts grown in vitro in a hepatoma cell line. , 1985, The American journal of tropical medicine and hygiene.

[29]  C. C. Campbell,et al.  In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax. , 1985, The American journal of tropical medicine and hygiene.

[30]  R. Sinden,et al.  Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. , 1982, The American journal of tropical medicine and hygiene.

[31]  P. Garnham,et al.  Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms. , 1982, The American journal of tropical medicine and hygiene.

[32]  W. Collins,et al.  Studies on human malaria in aotus monkeys. 3. Exoerythrocytic stages of the Salvador II strain of Plasmodium vivax. , 1973, The Journal of parasitology.

[33]  J. Rodhain.  Paradoxical behaviour of Plasmodium vivax in the chimpanzee. , 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  P. Garnham,et al.  Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. , 1948, British medical journal.

[35]  P. G. Shute,et al.  Pre-Erythrocytic Stage of Human Malaria, Plasmodium Vivax , 1948 .

[36]  M. Galinski,et al.  Plasmodium vivax: modern strategies to study a persistent parasite's life cycle. , 2013, Advances in parasitology.

[37]  R. Price,et al.  Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. , 2012, Advances in parasitology.

[38]  N. White,et al.  Chapter Two - Relapse , 2012 .

[39]  M. Markus.  Malaria: Origin of the Term “Hypnozoite” , 2011, Journal of the history of biology.

[40]  C. Guguen-Guillouzo,et al.  Cultivation of the liver forms of Plasmodium vivax in human hepatocytes , 1984, Nature.

[41]  P. Garnham,et al.  Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection. , 1982, The American journal of tropical medicine and hygiene.